LSL.V · LSL Pharma Group Inc.
Canada · RS rating 21 · As of 2026-10-14
| Price | 0.29 CAD |
|---|---|
| 1-day change | -1.7% |
| RS rating (overall / 1M / 3M / 12M) | 21 / 39 / 28 / 27 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 15 / 18 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +18.9% |
| Distance from 52-week high | +46.4% |
| Market cap (USD) | $26.3M |